相关实验视频

Updated: May 9, 2025

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

87

格林的表达可以调节二度心脏功能在2型糖尿病肥胖患者?

Celestino Sardu1, Nunzia D'Onofrio2, Maria Consiglia Trotta2

  • 1Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.

Diabetes/metabolism research and reviews
|May 5, 2025
PubMed
概括

在患有2型糖尿病 (T2DM) 肥胖患者的腹部脂肪切除减少了炎症,改善了左心室扩张功能 (LV-DF). 这种干预增加了血清胆固醇和与LV-DF正常化相关的特定微RNA (miRs).

关键词:
这是一个微型RNA.一个SIRT1系统.腹部脂肪 - 腹部脂肪腹部整形术是一种腹部整形术.格林激素是什么 格林激素是什么肥胖 肥胖 肥胖 肥胖 肥胖 肥胖 肥胖 肥胖氧化应激是一种氧化应激.

更多相关视频

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice10:28

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice

Published on: May 24, 2018

15.3K
Sleeve Gastrectomy in Mice using Surgical Clips05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

6.5K

相关概念视频

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
250